Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).

  • S H L Thomas
  • M D Drici
  • G C Hall
  • M A Crocq
  • B Everitt
  • M H Lader
  • C Le Jeunne
  • Dieter Naber
  • S Priori
  • M Sturkenboom
  • F Thibaut
  • J Peuskens
  • A Mittoux
  • P Tanghøj
  • M Toumi
  • N D Moore
  • R D Mann

Abstract

To explore whether sertindole increases all-cause mortality or cardiac events requiring hospitalization, compared with risperidone.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer5
ISSN0001-690X
StatusVeröffentlicht - 2010
pubmed 20384598